{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:47:35Z","timestamp":1790938055539,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.parkreldis.2014.10.010","type":"journal-article","created":{"date-parts":[[2014,10,18]],"date-time":"2014-10-18T22:04:21Z","timestamp":1413669861000},"page":"1329-1334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-9468","authenticated-orcid":false,"given":"C.","family":"Comi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Magistrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.D.","family":"Oggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fleetwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cantello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2014.10.010_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/ene.12022","article-title":"EFNS\/MDS-ES\/ENS [corrected] recommendations for the diagnosis of Parkinson's disease","volume":"20","author":"Berardelli","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.parkreldis.2014.05.005","article-title":"Multiple system atrophy as emerging template for accelerated drug discovery in \u03b1-synucleinopathies","volume":"20","author":"Krismer","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib3","first-page":"89","article-title":"Immunity and inflammation in neurodegenerative disease","volume":"21","author":"Cappellano","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib4","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","article-title":"When does Parkinson disease start?","volume":"67","author":"Savica","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/acn3.78","article-title":"\u03b1-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism","volume":"1","author":"Rodr\u00edguez-Leyva","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/NEN.0b013e3182801cde","article-title":"Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease","volume":"72","author":"Mu","year":"2013","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/NEN.0b013e3182965886","article-title":"Parkinson disease affects peripheral sensory nerves in the pharynx","volume":"72","author":"Mu","year":"2013","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"S2","key":"10.1016\/j.parkreldis.2014.10.010_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson's disease","volume":"38","author":"Wakabayashi","year":"1997","journal-title":"Eur Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","article-title":"Pathological correlates of gastrointestinal dysfunction in Parkinson's disease","volume":"46","author":"Cerosimo","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib12","first-page":"81","article-title":"Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease","volume":"113","author":"Orimo","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2010.01380.x","article-title":"Are dysautonomic and sensory symptoms present in early Parkinsons disease?","volume":"122","author":"Tysnes","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.2010.06832.x","article-title":"Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain","volume":"114","author":"Siebert","year":"2010","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/awn102","article-title":"Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation","volume":"131","author":"Nolano","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neulet.2009.12.027","article-title":"Clinical availability of skin biopsy in the diagnosis of Parkinson's disease","volume":"469","author":"Miki","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22330","article-title":"Neuropathy in idiopathic Parkinson disease: an iatrogenic problem?","volume":"69","author":"Nolano","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","article-title":"\u03b1-synuclein in cutaneous autonomic nerves","volume":"81","author":"Wang","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson's disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jns5.12056","article-title":"Intra-axonal protein aggregation in the peripheral nervous system","volume":"19","author":"Vital","year":"2014","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/mds.25149","article-title":"Hearing impairment in Parkinson's disease: expanding the nonmotor phenotype","volume":"27","author":"Vitale","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib25","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and Levodopa in Parkinson's disease: evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as potential complication of levodopa use in Parkinson's disease","volume":"23","author":"Toth","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson disease: prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00702-009-0275-0","article-title":"Peripheral COMT inhibition prevents levodopa associated homocysteine increase","volume":"116","author":"M\u00fcller","year":"2009","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneur.61.5.657","article-title":"Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration","volume":"61","author":"M\u00fcller","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2012.00408.x","article-title":"Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects","volume":"17","author":"Gonz\u00e1lez","year":"2012","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/gerona\/glr202","article-title":"Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs","volume":"67","author":"Leishear","year":"2012","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1532-5415.2012.03998.x","article-title":"Relationship between vitamin B12 and sensory and motor peripheral nerve function in older adults","volume":"60","author":"Leishear","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(84)90147-3","article-title":"The peripheral neuropathy of vitamin B12 deficiency","volume":"66","author":"McCombe","year":"1984","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","article-title":"Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens","volume":"20","author":"Mancini","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1179\/016164106X110445","article-title":"Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations","volume":"28","author":"Ozer","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12106","article-title":"Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta analysis","volume":"128","author":"Hu","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib38","doi-asserted-by":"crossref","unstructured":"Todorovi\u0107 Z, D\u017eolji\u0107 E, Novakovi\u0107 I, Mirkovi\u0107 D, Stojanovi\u0107 R, Krajinovi\u0107 M et\u00a0al. Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy. J Neurol Sci;248:56\u201361.","DOI":"10.1016\/j.jns.2006.05.040"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12017-012-8174-1","article-title":"Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients","volume":"14","author":"Gorgone","year":"2012","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00702-014-1204-4","article-title":"Subacute peripheral neuropathy under duodopa therapy without cobalamin deficiency and despite supplementation","volume":"121","author":"Lehnerer","year":"2014","journal-title":"J\u00a0Neural Transm"},{"issue":"S3","key":"10.1016\/j.parkreldis.2014.10.010_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1353-8020(09)70821-1","article-title":"Emergencies in parkinsonism: akinetic crisis, life-treatering dyskinesia, and polyneuropathy during l-dopa gel treatment","volume":"15","author":"Onofrj","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib42","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/mds.23342","article-title":"Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy","volume":"25","author":"Urban","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib43","first-page":"1668","article-title":"Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert","volume":"259","author":"Santos-Garc\u00eda","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.22258","article-title":"A\u00a0case series of peripheral neuropathy in patients with Parkinson's disease","volume":"68","author":"Gondim Fde","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.parkreldis.2013.05.002","article-title":"Severe ataxic polyneuropathy associated with chronic levodopa use in Parkinson's disease","volume":"19","author":"Kimber","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.parkreldis.2013.08.007","article-title":"Guillain-Barre\/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa\/carbidopa treatment","volume":"20","author":"Galazky","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0b013e3180ed449f","article-title":"Enteral Levodopa\/Carbidopa infusion in advanced Parkinson's disease: long-term exposure","volume":"31","author":"Nyholm","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib48","doi-asserted-by":"crossref","first-page":"e66639","DOI":"10.1371\/journal.pone.0066639","article-title":"Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs","volume":"8","author":"Jugel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mds.21500","article-title":"Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome","volume":"22","author":"Antonini","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib50","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mds.22807","article-title":"Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy","volume":"24","author":"Manca","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mds.23408","article-title":"Transcutaneous port for continuous duodenal levodopa\/carbidopa administration in Parkinson's disease","volume":"26","author":"Meppelink","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2013.02.006","article-title":"Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery","volume":"19","author":"M\u00fcller","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-011-0689-3","article-title":"Malnutritional neuropathy under intestinal levodopa infusion","volume":"119","author":"Klostermann","year":"2012","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib54","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ane.12164","article-title":"Prospective assessment of peripheral neuropathy in Duodopa treated parkinsonian patients","volume":"129","author":"Merola","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11940-009-0052-2","article-title":"Prevention and treatment of peripheral neuropathy after bariatric surgery","volume":"12","author":"Rudnicki","year":"2010","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1574-6941.2011.01279.x","article-title":"Effects of a symbiotic on microbial community structure in a continuous culture model of gastric microbiota in enteral nutrition patients","volume":"80","author":"Smith","year":"2012","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib57","first-page":"201657","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations","volume":"2014","author":"Ripellino","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib58","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.23760","article-title":"Has \u201cLevodopa-induced neuropathy\u201d been reported in Parkinson's disease clinical trial?","volume":"26","author":"Teodoro","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2014.10.010_bib59","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.22878","article-title":"Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view","volume":"25","author":"Montastruc","year":"2010","journal-title":"Mov Disord"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014003794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802014003794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T02:55:48Z","timestamp":1717469748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802014003794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1353802014003794"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.010","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral nervous system involvement in Parkinson's disease: Evidence and controversies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2014.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}